Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glaucoma, Stem Cells, and Gene Therapy: Where Are We Now?

28 Aug 2017

Abstract excerpt

Glaucoma is the second most common cause of blindness, affecting 70∼80 million people around the world. The death of retinal ganglion cells (RGCs) is the main cause of blindness related to this disease. Current therapies do not provide enough protection and regeneration of RGCs. A novel opportunity for treatment of glaucoma is application of technologies related to stem cell and gene therapy. In this perspective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Retinopathy of Prematurity Studies
Share to Corneal Surgery and Treatments
Share to Retinal Development and Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28844129
DOI: 10.15283/ijsc17029

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glaucoma, Stem Cells, and Gene Therapy: Where Are We Now?PMID 28844129Read ↗

Glaucoma as a Neurodegenerative Disease Caused by Intrinsic Vulnerability Factors.Semantic proximity Read ↗

The concept of gene therapy for glaucomaSemantic proximity Read ↗

Glaucoma: genes, phenotypes, and new directions for therapy.Semantic proximity Read ↗

Regenerative medicine in the retina: from stem cells to cell replacement therapySemantic proximity Read ↗

Genetic Aspects of Glaucoma: An Updated Review.Semantic proximity Read ↗

Survival of Transplanted Retinal Ganglion Cell in Human Donor Eyes under Elevated PressureSemantic proximity Read ↗

Recent patents and developments in glaucoma biomarkers.Semantic proximity Read ↗

Stem Cell Transplantation Rescued A Primary Open-Angle Glaucoma Mouse ModelSemantic proximity Read ↗

Stem cell transplantation rescued a primary open-angle glaucoma mouse modelSemantic proximity Read ↗

Stem Cell Therapy for Retinal Degeneration: The Evidence to DateSemantic proximity Read ↗

Use of Gene Therapy in Retinal Ganglion Cell Neuroprotection: Current Concepts and Future DirectionsSemantic proximity Read ↗

Gene Therapy Targeting Glaucoma: Where Are We?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.